Hypertension in chronic kidney disease: Navigating the evidence

International Journal of Hypertension

Volumn 2011, Issue , 2011, Pages

  Tedla, F M ^a   Brar, A ^a   Browne, R ^a   Brown, C ^a  

^a SUNY Downstate Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IRBESARTAN; LOOP DIURETIC AGENT; LOSARTAN; PLACEBO; RAMIPRIL; TELMISARTAN;

BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; DIABETIC NEPHROPATHY; DIET THERAPY; ESSENTIAL HYPERTENSION; EXERCISE; HEMODIALYSIS; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY ARTERY STENOSIS; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LIFESTYLE MODIFICATION; NEPHROSCLEROSIS; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; RENAL PROTECTION; REVIEW;

EID: 80055108944     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.4061/2011/132405     Document Type: Review

References (87)

1. Sinclair A. M., Isles C. G., Brown I., Cameron H., Murray G. D., Robertson J. W., Secondary hypertension in a blood pressure clinic. Archives of Internal Medicine 1987 147 1289 1293
2. Go A. S., Chertow G. M., Fan D., McCulloch C. E., Hsu C. Y., Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New England Journal of Medicine 2004 351 13 1296 1305 2-s2.0-4644221457 10.1056/NEJMoa041031 (Pubitemid 39268908)
3. Anavekar N. S., McMurray J. J. V., Velazquez E. J., Solomon S. D., Kober L., Rouleau J. L., White H. D., Nordlander R., Maggioni A., Dickstein K., Zelenkofske S., Leimberger J. D., Califf R. M., Pfeffer M. A., Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. New England Journal of Medicine 2004 351 13 1285 1295 2-s2.0-4544327596 10.1056/NEJMoa041365 (Pubitemid 39258422)
4. Levey A. S., Coresh J., Bolton K., Culleton B., Harvey K. S., Ikizler T. A., Johnson C. A., Kausz A., Kimmel P. L., Kusek J., Levin A., Minaker K. L., Nelson R., Rennke H., Steffes M., Witten B., Hogg R. J., Furth S., Lemley K. V., Portman R. J., Schwartz G., Lau J., Balk E., Perrone R. D., Karim T., Rayan L., Al-Massry I., Chew P., Astor B. C., De Vine D., Eknoyan G., Levin N., Burrows-Hudson S., Keane W., Kliger A., Latos D., Mapes D., Oberley E., Willis K., Bailie G., Becker G., Burrowes J., Churchill D., Collins A., Couser W., DeZeeuw D., Garber A., Golper T., Gotch F., Gotto A., Greer J. W., Grimm R., Hannah R. G., Acosta J. H., Hogg R., Hunsicker L., Klag M., Klahr S., Lewis C., Lowrie E., Matas A., McCulloch S., Michael M., Nally J. V., Newmann J. M., Nissenson A., Norris K., Owen W., Patel T. G., Payne G., Rivera-Mizzoni R. A., Smith D., Star R., Steinman T., Valderrabano F., Walls J., Wauters J. P., Wenger N., Briggs J., K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. American Journal of Kidney Diseases 2002 39 2 S1 S266 2-s2.0-0036176161
5. Coresh J., Selvin E., Stevens L. A., Manzi J., Kusek J. W., Eggers P., Van Lente F., Levey A. S., Prevalence of chronic kidney disease in the United States. Journal of the American Medical Association 2007 298 17 2038 2047 2-s2.0-35848968871 10.1001/jama.298.17.2038 (Pubitemid 350074801)
6. Turnbull F., Effects of different blood-pressure-lowering regimens on major cardiovascular events: Results of prospectively-designed overviews of randomised trials. Lancet 2003 362 9395 1527 1535 2-s2.0-0242654867 10.1016/S0140-6736(03)14739-3 (Pubitemid 37410190)
7. Egan B. M., Zhao Y., Axon R. N., US trends in prevalence, awareness, treatment, and control of hypertension, 19882008. Journal of the American Medical Association 2010 303 20 2043 2050 2-s2.0-77952750659 10.1001/jama.2010.650
8. U S Renal Data System, USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, Md, USA, 2010
9. Ridao N., Luño J., García De Vinuesa S., Gómez F., Tejedor A., Valderrábano F., Prevalence of hypertension in renal disease. Nephrology Dialysis Transplantation 2001 16 1 70 73 2-s2.0-0035009836 (Pubitemid 32492510)
10. Muntner P., Anderson A., Charleston J., Chen Z., Ford V., Makos G., O'Connor A., Perumal K., Rahman M., Steigerwalt S., Teal V., Townsend R., Weir M., Wright J. T., Hypertension awareness, treatment, and control in adults with CKD: results from the chronic renal insufficiency cohort (CRIC) study. American Journal of Kidney Diseases 2010 55 3 441 451 2-s2.0-77049112022 10.1053/j.ajkd.2009.09.014
11. Muntner P., Judd S. E., Krousel-Wood M., McClellan W. M., Safford M. M., Low medication adherence and hypertension control among adults with CKD: data from the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study. American Journal of Kidney Diseases 2010 56 447 457 2-s2.0-77951995500 10.1053/j.ajkd.2010.02.348
12. Snyder J. J., Collins A. J., KDOQI hypertension, dyslipidemia, and diabetes care guidelines and current care patterns in the united states CKD population: National health and nutrition examination survey 1999-2004. American Journal of Nephrology 2009 30 1 44 54 2-s2.0-59449108700 10.1159/000201014
13. Sarafidis P. A., Li S., Chen S. C., Collins A. J., Brown W. W., Klag M. J., Bakris G. L., Hypertension awareness, treatment, and control in chronic kidney disease. American Journal of Medicine 2008 121 4 332 340 2-s2.0-41249093134 10.1016/j.amjmed.2007.11.025 (Pubitemid 351444786)
14. Bangash F., Agarwal R., Masked hypertension and white-coat hypertension in chronic kidney disease: A meta-analysis. Clinical Journal of the American Society of Nephrology 2009 4 3 656 664 2-s2.0-66149147915 10.2215/CJN.05391008
15. Agarwal R., Lewis R. R., Prediction of hypertension in chronic hemodialysis patients. Kidney International 2001 60 5 1982 1989 2-s2.0-0034778611 10.1046/j.1523-1755.2001.00997.x (Pubitemid 33000005)
16. Agarwal R., Nissenson A. R., Batlle D., Coyne D. W., Trout J. R., Warnock D. G., Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. American Journal of Medicine 2003 115 4 291 297 2-s2.0-0041878535 10.1016/S0002-9343(03)00366-8 (Pubitemid 37088191)
17. Cocchi R., Esposti E. D., Fabbri A., Lucatello A., Sturani A., Quarello F., Boero R., Bruno M., Dadone C., Favazza A., Scanziani R., Tommasi A., Giangrande A., Prevalence of hypertension in patients on peritoneal dialysis: results of an Italian multicentre study. Nephrology Dialysis Transplantation 1999 14 6 1536 1540 2-s2.0-0344348945 10.1093/ndt/14.6.1536 (Pubitemid 29241751)
18. Tedla F., Hayashi R., McFarlane S. I., Salifu M. O., Hypertension after renal transplant. Journal of Clinical Hypertension 2007 9 7 538 545 2-s2.0-34648825736 10.1111/j.1524-6175.2007.06588.x
19. Lynn K. L., Hypertension and survival in hemodialysis patients. Seminars in Dialysis 2004 17 4 270 274 2-s2.0-4243072913 10.1111/j.0894-0959.2004.17325.x (Pubitemid 39107648)
20. Chertow G. M., Levin N. W., Beck G. J., Depner T. A., Eggers P. W., Gassman J. J., Gorodetskaya I., Greene T., James S., Larive B., Lindsay R. M., Mehta R. L., Miller B., Ornt D. B., Rajagopalan S., Rastogi A., Rocco M. V., Schiller B., Sergeyeva O., Schulman G., Ting G. O., Unruh M. L., Star R. A., Kliger A. S., In-center hemodialysis six times per week versus three times per week. New England Journal of Medicine 2010 363 24 2287 2300 10.1056/ NEJMoa1001593
21. Kasiske B. L., Anjum S., Shah R., Skogen J., Kandaswamy C., Danielson B., O'Shaughnessy E. A., Dahl D. C., Silkensen J. R., Sahadevan M., Snyder J. J., Hypertension after kidney transplantation. American Journal of Kidney Diseases 2004 43 6 1071 1081 2-s2.0-2542464211 (Pubitemid 38691503)
22. Opelz G., Döhler B., Improved long-term outcomes after renal transplantation associated with blood pressure control. American Journal of Transplantation 2005 5 11 2725 2731 2-s2.0-33644796696 10.1111/j.1600-6143.2005. 01093.x
23. Guyton A. C., Coleman T. G., Young D. B., Lohmeier T. E., DeClue J. W., Salt balance and long-term blood pressure control. Annual Review of Medicine 1980 31 15 27 2-s2.0-0018861154
24. Hall J. E., The kidney, hypertension, and obesity. Hypertension 2003 41 3 625 633 2-s2.0-0037340168 10.1161/01.HYP.0000052314.95497.78 (Pubitemid 36314565)
25. Curtis J. J., Luke R. G., Dustan H. P., Remission of essential hypertension after renal transplantation. New England Journal of Medicine 1983 309 17 1009 1015 2-s2.0-0020523757 (Pubitemid 13014770)
26. Widgren B. R., Herlitz H., Hedner T., Berglund G., Wikstrand J., Jonsson O., Andersson O. K., Blunted renal sodium excretion during acute saline loading in normotensive men with positive family histories of hypertension. American Journal of Hypertension 1991 4 7 I 570 578 2-s2.0-0025886969
27. Keller G., Zimmer G., Mall G., Ritz E., Amann K., Nephron number in patients with primary hypertension. New England Journal of Medicine 2003 348 2 101 108 2-s2.0-0037426760 10.1056/NEJMoa020549 (Pubitemid 36056716)
28. Saad E., Charra B., Raj D. S. C., Hypertension control with daily dialysis. Seminars in Dialysis 2004 17 4 295 298 2-s2.0-4243146154 10.1111/j.0894-0959.2004.17330.x (Pubitemid 39107653)
29. Günal A. I., Duman S., Özkahya M., Töz H., Asçi G., Akçiçek F., Basçi A., Strict volume control normalizes hypertension in peritoneal dialysis patients. American Journal of Kidney Diseases 2001 37 3 588 593 2-s2.0-0035123652 (Pubitemid 32195299)
30. Vasavada N., Agarwal R., Role of excess volume in the pathophysiology of hypertension in chronic kidney disease. Kidney International 2003 64 5 1772 1779 2-s2.0-0142249392 10.1046/j.1523-1755.2003.00273.x (Pubitemid 37323706)
31. Kim K. E., Onesti G., Schwartz A. B., Chinitz J. L., Swartz C., Hemodynamics of hypertension in chronic end-stage renal disease. Circulation 1972 46 3 456 464 2-s2.0-0015395019
32. Weidmann P., Maxwell M. H., Lupu A. N., Lewin A. J., Massry S. G., Plasma renin activity and blood pressure in terminal renal failure. New England Journal of Medicine 1971 285 14 757 762 2-s2.0-0015245999
33. Vaughan E. D. Jr., Carey R. M., Ayers C. R., Peach M. J., Hemodialysis-resistant hypertension: Control with an orally active inhibitor of angiotensin-converting enzyme. Journal of Clinical Endocrinology and Metabolism 1979 48 5 869 871 2-s2.0-0018764702 (Pubitemid 9172128)
34. Augustyniak R. A., Tuncel M., Zhang W., Toto R. D., Victor R. G., Sympathetic overactivity as a cause of hypertension in chronic renal failure. Journal of Hypertension 2002 20 1 3 9 2-s2.0-0036057776 10.1097/00004872- 200201000-00002 (Pubitemid 34913395)
35. Chapman A. B., Johnson A., Gabow P. A., Schrier R. W., The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. New England Journal of Medicine 1990 323 16 1091 1096 2-s2.0-0025047248 (Pubitemid 20370729)
36. Kohan D. E., Endothelins in the normal and diseased kidney. American Journal of Kidney Diseases 1997 29 1 2 26 2-s2.0-0031026198 (Pubitemid 27020792)
37. Blaustein M. P., Zhang J., Chen L., Song H., Raina H., Kinsey S. P., Izuka M., Iwamoto T., Kotlikoff M. I., Lingrel J. B., Philipson K. D., Wier W. G., Hamlyn J. M., The pump, the exchanger, and endogenous ouabain: signaling mechanisms that link salt retention to hypertension. Hypertension 2009 53 2 291 298 2-s2.0-59849096582 10.1161/HYPERTENSIONAHA.108.119974
38. Vaziri N. D., Effect of chronic renal failure on nitric oxide metabolism. American Journal of Kidney Diseases 2001 38 4 S74 S79 2-s2.0-0034816866 (Pubitemid 32927617)
39. Mitas J. A., Levy S. B., Holle R., Urinary kallikrein activity in the hypertension of renal parenchymal disease. New England Journal of Medicine 1978 299 4 162 165 2-s2.0-0018139958 (Pubitemid 8396221)
40. Dunn M. J., Hood V. L., Prostaglandins and the kidney. The American Journal of Physiology 1977 233 3 169 184 2-s2.0-0017528293 (Pubitemid 8210973)
41. Vaziri N. D., Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension. Current Opinion in Nephrology and Hypertension 2004 13 1 93 99 2-s2.0-4043107129 10.1097/00041552-200401000-00013 (Pubitemid 39069904)
42. McNally P. G., Feehally J., Pathophysiology of cyclosporin A nephrotoxicity: experimental and clinical observations. Nephrology Dialysis Transplantation 1992 7 8 791 804 2-s2.0-0026711085
43. Foley R. N., Murray A. M., Li S., Herzog C. A., McBean A. M., Eggers P. W., Collins A. J., Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States medicare population, 1998 to 1999. Journal of the American Society of Nephrology 2005 16 2 489 495 2-s2.0-20544467918 10.1681/ASN.2004030203 (Pubitemid 41725146)
44. Keith D. S., Nichols G. A., Gullion C. M., Brown J. B., Smith D. H., Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Archives of Internal Medicine 2004 164 6 659 663 2-s2.0-1642413198 10.1001/archinte.164.6.659 (Pubitemid 38392981)
45. U.S. Renal Data System, USRDS 2008 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Md, USA, 2008
46. Chobanian A. V., Bakris G. L., Black H. R., Cushman W. C., Green L. A., Izzo J. L., Jones D. W., Materson B. J., Oparil S., Wright J. T., Roccella E. J., The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. Journal of the American Medical Association 2003 289 19 2560 2572 2-s2.0-0038460302 10.1001/jama.289.19.2560 (Pubitemid 37430158)
47. Levey A. S., Rocco M. V., Anderson S., Andreoli S. P., Bailie G. R., Bakris G. L., Callahan M. B., Greene J. H., Johnson C. A., Lash J. P., McCullough P. A., Miller E. R., Nally J. V., Pirsch J. D., Portman R. J., Sevick M. A., Sica D., Wesson D. E., Agodoa L., Bolton K., Cutler J. A., Hostetter T., Lau J., Uhlig K., Chew P., Kausz A., Kupelnick B., Raman G., Sarnak M., Wang C., Astor B. C., Eknoyan G., Levin A., Levin N., Bailie G., Becker B., Becker G., Burrowes J., Carrera F., Churchill D., Collins A., Crooks P. W., DeZeeuw D., Golper T., Gotch F., Gotto A., Greenwood R., Greer J. W., Grimm R., Haley W. E., Hogg R., Hull A. R., Hunsicker L., Klag M., Klahr S., Lameire N., Locatelli F., McCulloch S., Michael M., Newmann J. M., Nissenson A., Norris K., Obrador G., Owen W., Patel T. G., Payne G., Ronco C., Rivera-Mizzoni R. A., Schoolwerth A. C., Star R., Steffes M., Steinman T., Wauters J. P., Wenger N., Briggs J., Burrows-Hudson S., Latos D., Mapes D., Oberley E., Pereira B. J. G., Willis K., Gucciardo A., Fingerhut D., Klette M., Schachne E., K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. American Journal of Kidney Diseases 2004 43 5 S1 S290 2-s2.0-17044450690
48. Weiner D. E., Tighiouart H., Levey A. S., Elsayed E., Griffith J. L., Salem D. N., Sarnak M. J., Lowest systolic blood pressure is associated with stroke in stages 3 to 4 chronic kidney disease. Journal of the American Society of Nephrology 2007 18 3 960 966 2-s2.0-33947244300 10.1681/ASN.2006080858 (Pubitemid 46434513)
49. Berl T., Hunsicker L. G., Lewis J. B., Pfeffer M. A., Porush J. G., Rouleau J. L., Drury P. L., Esmatjes E., Hricik D., Pohl M., Raz I., Vanhille P., Wiegmann T. B., Wolfe B. M., Locatelli F., Goldhaber S. Z., Lewis E. J., Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial. Journal of the American Society of Nephrology 2005 16 7 2170 2179 2-s2.0-27744542905 10.1681/ASN.2004090763 (Pubitemid 41716450)
50. Probstfield J. L., Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). Journal of the American Medical Association 1991 265 24 3255 3264 10.1001/jama.265.24.3255
51. Viberti G., Mogensen C. E., Groop L. C., Pauls J. F., Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. Journal of the American Medical Association 1994 271 4 275 279 10.1001/jama.271.4.275 (Pubitemid 24030753)
52. Boner G., Van Dyk D. J., Tan M. H., Tan J., Ekstrand A., Koivisto V. A., Groop L. C., Groop P. H., Lucas A., Romero R., Salinas I., Sanmarti A., Escobar F., Escobar-Jimenez F., Campos-Pastor M. M., Mugoz M., Gomez M., Mangili R., Pozza G., Spotti D., Hansen K. W., Christiansen J. S., Klein F., Mogensen C. E., Van Doorn L. G., Spooren P. F. M. J., Cruickshank J. K., Jervell J., Paus P. N., Barnes D. J., Collins A., Viberti G. C., Williams G., Nelstrop G. A., Amorosa L., Anolik J. R., Aronoff S. L., Eubank B., Bailie M., Pelletier L., Blevins T., Charles M. A., Perry M., Clarke D., Tomkey D., Einhorn D., Humphries D., Garber A. J., Haag B., Williams E., Hoy W., Watkins M., Kahkonen D., Kruger D., Kilo C., Laffel L., Golden E., Lodewick P., Lovinsky., Mason J., Johnson S., McGill J., Schmidt L., Orlander P., Sorenson K., Raskin P., Hellenbrand D., Rosenblatt S., Schwartz S., Aufieri J., Sheehan J. P., Ulchaker M., Skyler J. S., Agramonte R., Starr J., Gagliastre D., Taylor T., Dawn K., Ward W. K., Rigdon M., Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. Diabetologia 1996 39 5 587 593 2-s2.0-0342636985 10.1007/s001250050482 (Pubitemid 26135462)
53. Lewis E. J., Hunsicker L. G., Bain R. P., Rohde R. D., The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. New England Journal of Medicine 1993 329 20 1456 1462 10.1056/NEJM199311113292004 (Pubitemid 23335891)
54. Lewis E. J., Hunsicker L. G., Clarke W. R., Berl T., Pohl M. A., Lewis J. B., Ritz E., Atkins R. C., Rohde R., Raz I., Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. New England Journal of Medicine 2001 345 12 851 860 2-s2.0-0035922447 10.1056/NEJMoa011303
55. Brenner B. M., Cooper M. E., De Zeeuw D., Keane W. F., Mitch W. E., Parving H. H., Remuzzi G., Snapinn S. M., Zhang Z., Shahinfar S., Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. New England Journal of Medicine 2001 345 12 861 869 2-s2.0-0035922441 10.1056/NEJMoa011161
56. Estacio R. O., Jeffers B. W., Gifford N., Schrier R. W., Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care 2000 23 2 B54 B64 2-s2.0-0034074955 (Pubitemid 30185779)
57. Schrier R. W., Estacio R. O., Esler A., Mehler P., Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney International 2002 61 3 1086 1097 2-s2.0-0036190137 10.1046/j.1523-1755.2002.00213.x (Pubitemid 34175478)
58. Klahr S., Levey A. S., Beck G. J., Caggiula A. W., Hunsicker L., Kusek J. W., Striker G., The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. New England Journal of Medicine 1994 330 13 877 884 10.1056/NEJM199403313301301 (Pubitemid 24094966)
59. UK Prospective Diabetes Study Group, Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. British Medical Journal 1999 317 703 713
60. Adler A. I., Stratton I. M., Neil H. A. W., Yudkin J. S., Matthews D. R., Cull C. A., Wright A. D., Turner R. C., Holman R. R., Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. British Medical Journal 2000 321 7258 412 419 2-s2.0-0034641550 (Pubitemid 30609443)
61. Pohl M. A., Blumenthal S., Cordonnier D. J., De Alvaro F., DeFerrari G., Eisner G., Esmatjes E., Gilbert R. E., Hunsicker L. G., Lopes De Faria J. B., Mangili R., Moore J., Reisin E., Ritz E., Schernthaner G., Spitalewitz S., Tindall H., Rodby R. A., Lewis E. J., Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: Clinical implications and limitations. Journal of the American Society of Nephrology 2005 16 10 3027 3037 2-s2.0-33644912981 10.1681/ASN.2004110919 (Pubitemid 44743500)
62. Sarnak M. J., Greene T., Wang X., Beck G., Kusek J. W., Collins A. J., Levey A. S., The effect of a lower target blood pressure on the progression of kidney disease: Long-term follow-up of the modification of diet in renal disease study. Annals of Internal Medicine 2005 142 5 342 351 2-s2.0-14344255910 (Pubitemid 40293407)
63. Cushman W. C., Evans G. W., Byington R. P., Goff D. C., Grimm R. H., Cutler J. A., Simons-Morton D. G., Basile J. N., Corson M. A., Probstfield J. L., Katz L., Peterson K. A., Friedewald W. T., Buse J. B., Bigger J. T., Gerstein H. C., Ismail-Beigi F., Effects of intensive blood-pressure control in type 2 diabetes mellitus. New England Journal of Medicine 2010 362 17 1575 1585 2-s2.0-77951735232 10.1056/NEJMoa1001286
64. Remuzzi G., Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 1996 349 9069 1857 1863 10.1016/S0140-6736(96)11445-8 (Pubitemid 27270118)
65. Ruggenenti P., Perna A., Loriga G., Ganeva M., Ene-Iordache B., Turturro M., Lesti M., Perticucci E., Chakarski I. N., Leonardis D., Garini G., Sessa A., Basile C., Alpa M., Scanziani R., Sorba G., Zoccali C., Remuzzi G., Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial. Lancet 2005 365 9463 939 946 2-s2.0-15844414184 10.1016/S0140-6736(05)71082-5 (Pubitemid 41071427)
66. Li P. K. T., Leung C. B., Chow K. M., Cheng Y. L., Fung S. K. S., Mak S. K., Tang A. W. C., Wong T. Y. H., Yung C. Y., Yung J. C. U., Yu A. W. Y., Szeto C. C., Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study. American Journal of Kidney Diseases 2006 47 5 751 760 2-s2.0-33646483060 10.1053/j.ajkd.2006.01.017
67. Wright J. T. Jr., Bakris G., Greene T., Agodoa L. Y., Appel L. J., Charleston J., Cheek D., Douglas-Baltimore J. G., Gassman J., Glassock R., Hebert L., Jamerson K., Lewis J., Phillips R. A., Toto R. D., Middleton J. P., Rostand S. G., Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial. Journal of the American Medical Association 2002 288 19 2421 2431 10.1001/jama.288.19.2421 (Pubitemid 35340538)
68. Appel L. J., lappel@jhmi.edu Wright Jr. J. T., Greene T., Agodoa L. Y., Astor B. C., Bakris G. L., Cleveland W. H., Charleston J., Contreras G., Faulkner M. L., Gabbai F. B., Gassman J. J., Hebert L. A., Jamerson K. A., Kopple J. D., Kusek J. W., Lash J. P., Lea J. P., Lewis J. B., Lipkowitz M. S., Massry S. G., Miller E. R., Norris K., Phillips R. A., Pogue V. A., Randall O. S., Rostand S. G., Smogorzewski M. J., Toto R. D., Wang X., Intensive blood-pressure control in hypertensive chronic kidney disease. New England Journal of Medicine 2010 363 10 918 929 10.1056/NEJMoa0910975
69. Maschio G., Alberti D., Janin G., Locatelli F., Mann J. F.E., Motolese M., Ponticelli C., Ritz E., Zucchelli P., Effect of the angiotensin-converting- enzyme inhibitor benazepril on the progression of chronic renal insufficiency. New England Journal of Medicine 1996 334 15 939 945 10.1056/NEJM199604113341502 (Pubitemid 26114159)
70. Schrier R., McFann K., Johnson A., Chapman A., Edelstein C., Brosnahan G., Ecder T., Tison L., Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study. Journal of the American Society of Nephrology 2002 13 7 1733 1739 2-s2.0-0036295073 10.1097/01.ASN.0000018407. 60002.B9 (Pubitemid 34700597)
71. Kunz R., Friedrich C., Wolbers M., Mann J. F. E., Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin-angiotensin system on proteinuria in renal disease. Annals of Internal Medicine 2008 148 1 30 48 2-s2.0-38049139424 (Pubitemid 351688350)
72. Yusuf S., Teo K. K., Pogue J., Dyal L., Copland I., Schumacher H., Dagenais G., Sleight P., Anderson C., Telmisartan, ramipril, or both in patients at high risk for vascular events. New England Journal of Medicine 2008 358 15 1547 1559 2-s2.0-42049107348 10.1056/NEJMoa0801317 (Pubitemid 351522739)
73. Navaneethan S. D., Nigwekar S. U., Sehgal A. R., Strippoli G. F. M., Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis. Clinical Journal of the American Society of Nephrology 2009 4 3 542 551 2-s2.0-66149131479 10.2215/CJN.04750908
74. Parving H. H., Persson F., Lewis J. B., Lewis E. J., Hollenberg N. K., Aliskiren combined with losartan in type 2 diabetes and nephropathy. New England Journal of Medicine 2008 358 23 2433 2446 2-s2.0-44849114597 10.1056/NEJMoa0708379 (Pubitemid 351793017)
75. Parving H. H., Brenner B. M., McMurray J. J. V., De Zeeuw D., Haffner S. M., Solomon S. D., Chaturvedi N., Ghadanfar M., Weissbach N., Xiang Z., Armbrecht J., Pfeffer M. A., Aliskiren trial in type 2 diabetes using cardio-renal endpoints (ALTITUDE): rationale and study design. Nephrology Dialysis Transplantation 2009 24 5 1663 1671 2-s2.0-65249182083 10.1093/ndt/gfn721
76. Kalra P. A., Guo H., Kausz A. T., Gilbertson D. T., Liu J., Chen S. C., Ishani A., Collins A. J., Foley R. N., Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney International 2005 68 1 293 301 2-s2.0-24944434721 10.1111/j.1523-1755.2005.00406.x (Pubitemid 43181388)
77. Missouris C. G., Buckenham T., Cappuccio F. P., MacGregor G. A., Renal artery stenosis: a common and important problem in patients with peripheral vascular disease. American Journal of Medicine 1994 96 1 10 14 2-s2.0-0028069564 10.1016/0002-9343(94)90109-0 (Pubitemid 24043646)
78. Chabova V., Schirger A., Stanson A. W., McKusick M. A., Textor S. C., Outcomes of atherosclerotic renal artery stenosis managed without revascularization. Mayo Clinic Proceedings 2000 75 5 437 444 2-s2.0-0034065155 (Pubitemid 30252365)
79. Webster J., Marshall F., Abdalla M., Dominiczak A., Edwards R., Isles C. G., Loose H., Main J., Padfield P., Russell I. T., Walker B., Watson M., Wilkinson R., Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Journal of Human Hypertension 1998 12 5 329 335 (Pubitemid 28274364)
80. Van Jaarsveld B. C., b.v.jaarsveld@utr.dianet.nl Krijnen P., Pieterman H., Derkx F. H.M., Deinum J., Postma C. T., Dees A., Woittiez A. J.J., Bartelink A. K.M., In 'T Veld A. J.M., Schalekamp M. A.D.H., The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. New England Journal of Medicine 2000 342 14 1007 1014 10.1056/NEJM200004063421403 (Pubitemid 30180647)
81. Bax L., Woittiez A. J. J., Kouwenberg H. J., Mali W. P. T. M., Buskens E., Beek F. J. A., Braam B., Huysmans F. T. M., Schultze Kool L. J., Rutten M. J. C. M., Doorenbos C. J., Aarts J. C. N. M., Rabelink T. J., Plouin P. F., Raynaud A., Van Montfrans G. A., Reekers J. A., Van Den Meiracker A. H., Pattynama P. M. T., Van De Ven P. J. G., Vroegindeweij D., Kroon A. A., De Haan M. W., Postma C. T., Beutler J. J., Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Annals of Internal Medicine 2009 150 12 840 848 2-s2.0-67449089069
82. Wheatley K., Ives N., Gray R., Kalra P. A., Moss J. G., Baigent C., Carr S., Chalmers N., Eadington D., Hamilton G., Lipkin G., Nicholson A., Scoble J., Revascularization versus medical therapy for renal-artery stenosis. New England Journal of Medicine 2009 361 20 1953 1962 2-s2.0-70449650655 10.1056/NEJMoa0905368
83. Cooper C. J., Murphy T. P., Matsumoto A., Steffes M., Cohen D. J., Jaff M., Kuntz R., Jamerson K., Reid D., Rosenfield K., Rundback J., Agostino R. D., Henrich W., Dworkin L., Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. American Heart Journal 2006 152 1 59 66 2-s2.0-33745659870 10.1016/j.ahj.2005.09.011 (Pubitemid 43974724)
84. Kuypers D. R. J., Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions. Drugs and Aging 2009 26 9 715 737 2-s2.0-69949163535 10.2165/11316480-000000000-00000
85. Formica R. N. Jr., Friedman A. L., Lorber M. I., Smith J. D., Eisen T., Bia M. J., A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period. Nephrology Dialysis Transplantation 2006 21 5 1389 1394 2-s2.0-33646198401 10.1093/ndt/gfk058
86. Scheffers I. J.M., Kroon A. A., Schmidli J., Jordan J., Tordoir J. J.M., Mohaupt M. G., Luft F. C., Haller H., Menne J., Engeli S., Ceral J., Eckert S., Erglis A., Narkiewicz K., Philipp T., De Leeuw P. W., p.deleeuw@intmed.unimaas. nl Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study. Journal of the American College of Cardiology 2010 56 15 1254 1258 10.1016/j.jacc.2010.03.089
87. Esler M. D., Krum H., Sobotka P. A., Schlaich M. P., Schmieder R. E., Böhm M., Mahfoud F., Sievert H., Wunderlich N., Rump L. C., Vonend O., Uder M., Lobo M., Caulfield M., Erglis A., Azizi M., Sapoval M., Thambar S., Persu A., Renkin J., Schunkert H., Weil J., Hoppe U. C., Walton T., Scheinert D., Binder T., Januszewicz A., Witkowski A., Ruilope L. M., Whitbourn R., Bruck H., Downes M., Lüscher T. F., Jardine A. G., Webster M. W., Zeller T., Sadowski J., Bartus K., Straley C. A., Barman N. C., Lee D. P., Witteles R. M., Bhalla V., Massaro J. M., Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. The Lancet 2010 376 9756 1903 1909 10.1016/S0140-6736(10) 62039-9